Just a few months ago, I wrote about the potential of Viemed as a value stock. Since then the share price has pretty much doubled, without much of a corresponding change in the business. As such, I have sold my shares.
The company has only reported once since I wrote about them, but I guess the efficient market *really* liked that report (lolz). In truth, it probably took some time for the market to find this one, as it was a spin-off that eventually got uplisted and investor-relationed etc., which helped get the story out.
It's possible I sold wayyy too early, as the growth potential of this company is massive. But at it's new price, I just couldn't get comfortable with the downside, especially since the prices they charge for most of their revenue is regulated by the government. A rate-cut could happen at any time, so I'd rather invest my money in a company with a lower multiple. Good luck to all!
Disclosure: No position